The study, published in the European Heart Journal, examined more than 1 million people aged 50 or older with data from 2012 ...

Immutep Limited’s IMMP share price has surged by 28.47%, which has investors questioning if this is right time to sell.

An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...

Harvey Jones says the GSK share price has dramatically underperformed FTSE 100 rival AstraZeneca, which has had a stellar run ...

Drugs giant GSK ‘well positioned’ to absorb potential US tariffs - It came as the FTSE 100 giant revealed a rise in sales as ...

In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

It reports that President Donald Trump has suggested duties of 25% on foreign drugs, which could cost firms such as AstraZeneca and GlaxoSmithKline billions of pounds. Analysis of Ministry of ...

GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first vaccine in Egypt approved by the Egyptian Drug Authority for the ...